Edward A. Fisher, MD

  • Specialties: Preventive Cardiology, Cardiology
  • Language: English
  • Phone: 212-263-0855

Credentials

Positions
  • Leon H. Charney Professor of Cardiovascular Medicine, Department of Medicine
  • Professor, Department of Pediatrics
  • Professor, Department of Cell Biology
  • Professor, Department of Microbiology
Board Certifications
  • American Board of Pediatrics - Pediatrics, 1981
Education and Training
  • Fellowship, Boston Children's Hospital, Gasteoenterology, 1982
  • Residency, Duke University Hospital, Pediatric Medicine, 1977
  • MD from New York University, 1975

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Affinity
    • Affinity
    • Affinity Exchange- Essential
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • Emblem
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • GHI
    • GHI HMO
  • HIP
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP EPO/PPO
    • HIP Essential
    • HIP Family Health
    • HIP HMO
    • HIP Medicaid
    • HIP Medicare
    • HIP POS
  • HealthSmart
    • HealthSmart (WTC)
  • Healthfirst
    • Healthfirst
    • Healthfirst Essential
  • Humana
    • Humana Medicare
  • Local 1199
    • Local 1199 PPO
  • MagnaCare
    • MagnaCare PPO
  • Medicare
    • Medicare
  • MetroPlus
    • MetroPlus Child Health
    • MetroPlus Essential
    • MetroPlus Exchange Plans
    • MetroPlus Family Health
    • MetroPlus Medicaid
    • MetroPlus Medicare
  • MultiPlan/PHCS
    • MultiPlan/PHCS PPO
  • NYS
    • NYS Empire Plan
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • Tricare
    • Tricare
  • UHC
    • UnitedHealthcare Community & State Plan
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
  • UPN
    • UPN Elite
  • WellCare
    • WellCare Child Health
    • WellCare Family Health
    • WellCare Medicaid
    • WellCare Medicare
NYULMC Center for the Prevention of Cardiovascular Disease

530 1st Avenue, HCC, Suite 4F
New York, NY 10016

Research My Research

Interests

lipoprotein metabolism, atherosclerosis

Research Summary

My laboratory is involved in two major themes of research: 1. The cell biology of hepatic lipid and lipoprotein metabolism: Atherogenic lipoproteins contain apoprotein B (apoB) and cholesteryl esters. The net production of apoB is determined not at the level of synthesis, but at the level of intracellular, pre-secretory, degradation. My lab has been the first to demonstrate a non-proteasomal pathway of apoB degradation regulated by dietary fatty acids, a process that may also be regulated by insulin. Importantly, this non-proteasomal pathway may be dysregulated in insulin-resistance (such as seen in adults, and, unfortunately, a growing number of adolescents, with type II diabetes or obesity) and, thereby, contribute to the over-production of atherogenic lipoproteins that increase the risk of coronary artery disease in these metabolic states. To further pursue the proteasomal and non-proteasomal regulation of apoB degradation, my laboratory is using cell and molecular biological approaches on experimental models as diverse as cell-free systems and tissue-specific knockout mice. 2. The molecular biology of vascular diseases. My laboratory is also interested in the molecular factors that regulate the progression and regression of atherosclerotic plaques, a disease process now known to begin in childhood. This research relies on mouse models of atherosclerosis and current projects focus on: the regression of plaques after the normalization of hyperlipidemia; the effects of HDL on plaque progression and regression; To get at the molecular levels that regulate changes induced by the various experimental conditions in specific arterial wall cell types, his laboratory has pioneered the use of laser capture microdissection to isolate plaque macrophages in order to study gene expression. Recently, by using novel mouse models developed by us and our collaborators and these powerful techniques, my laboratory has published reports that foam cells can leave plaques during regression and they require dendritic cell properties for this emigration. We also have an active collaboration in the imaging of atherosclerosis in living mice. With Dr. Zahi Fayad at Mount Sinai, we have recently shown that HDL particles can be converted to nanoplatforms to deliver MRI enhancing agents to plaques to better visulaize them. Our goal is to adapt these particles for molecular imaging purposes.

Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library.
represents one publication
Loading...

Publications

  • Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association

    Daugherty, Alan; Tall, Alan R; Daemen, Mat J A P; Falk, Erling; Fisher, Edward A; Garcia-Cardena, Guillermo; Lusis, Aldons J; Owens, A Phillip 3rd; Rosenfeld, Michael E; Virmani, Renu Daugherty, Alan; Tall, Alan R; Daemen, Mat J A P; Falk, Erling; Fisher, Edward A; Garcia-Cardena, Guillermo; Lusis, Aldons J; Owens, A Phillip 3rd; Rosenfeld, Michael E; Virmani, Renu
    Circulation research. 2017 Sep 01. 121 (6): e53-e79

  • Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association

    Daugherty, Alan; Tall, Alan R; Daemen, Mat J A P; Falk, Erling; Fisher, Edward A; Garcia-Cardena, Guillermo; Lusis, Aldons J; Owens, A Phillip 3rd; Rosenfeld, Michael E; Virmani, Renu Daugherty, Alan; Tall, Alan R; Daemen, Mat J A P; Falk, Erling; Fisher, Edward A; Garcia-Cardena, Guillermo; Lusis, Aldons J; Owens, A Phillip 3rd; Rosenfeld, Michael E; Virmani, Renu
    Arteriosclerosis, thrombosis, & vascular biology. 2017 Sep. 37 (9): e131-e157

  • Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention

    Weiss, Matthew C; Berger, Jeffrey S; Gianos, Eugenia; Fisher, Edward; Schwartzbard, Arthur; Underberg, James; Weintraub, Howard Weiss, Matthew C; Berger, Jeffrey S; Gianos, Eugenia; Fisher, Edward; Schwartzbard, Arthur; Underberg, James; Weintraub, Howard
    Journal of clinical lipidology. 2017 Jul 22. ?-?

Read All Publications (324)

Related News